Antibodies to human T-cell leukemia virus (HTLV-1) in non human primates from Senegal
Coursaget, P.; Barres, J.L.; Yvonnet, B.; Chiron, J.P.; Cornet, M.; Ferrara, L.; Eyraud, M.
Biomedicine and PharmacoTherapy 39(4): 198-199
1985
ISSN/ISBN: 0753-3322 PMID: 2998500 Document Number: 248438
Document emailed within 1 workday
Related Documents
Miwa, M.; Shimotohno, K.; Hoshino, H.; Fujino, M.; Sugimura, T. 1984: Detection of pX proteins in human T-cell leukemia virus (HTLV)-infected cells by using antibody against peptide deduced from sequences of X-IV DNA of HTLV-i and Xc DNA of HTLV-Ii proviruses Gan 75(9): 752-755Seniuta, N.B.; Iakovleva, L.S.; Stepina, V.N.; Buachidze, L.N.; Gurova, E.P.; Kologrivova, Z.A.; Kindiakov, V.M.; Gurtsevich, V.E. 1990: Screening of sera from the adult populations of some USSR regions for antibodies to the human T-cell leukemia virus type i (HTLV-I) Voprosy Virusologii 35(4): 309-312
Wantzin, G.L. 1986: Human T-cell leukemia (lymphoma) virus (HTLV-I) antibodies in Danish patients with cutaneous T-cell lymphoma Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 37(5): 263-265
Sierra Madero, J.G.; Ponce de León, S.; Ruiz Palacios, G.; Tinoco, J.C.; Calva, J.J.; Zamora, E.E. 1986: Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type IIi (LAV/HTLV) in a population of homosexuals in Mexico Salud Publica de Mexico 28(2): 180-185
Sierra Madero, J.G.; Ponce de León, S.; Ruiz Palacios, G.; Tinoco, J.C.; Calva, J.J.; Zamora, E.E. 1986: Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type IIi (LAV/HTLV) in a population of homosexuals in Mexico Salud Publica de Mexico 28(2): 180-185
Hrusková-Heidingsfeldová, O.; Bláha, I.; Urban, J.; Strop, P.; Pichová, I. 1997: Substrates and inhibitors of human T-cell leukemia virus type 1 (HTLV-1) proteinase Leukemia 11(Suppl 3): 45-46
Nakao, K.; Isashiki, Y.; Uto, M.; Ohba, N.; Kawano, K. 1994: Antibodies to human T-cell lymphotropic virus type 1 in the aqueous humor of HTLV-I associated uveitis Nippon Ganka Gakkai Zasshi 98(9): 866-871
Kilim, Y.; Rosenblatt, J.D.; Danon, Y.L. 1994: Sequence analysis of the new human T cell leukemia/lymphoma virus type i isolate (HTLV-I) in Israel Israel Journal of Medical Sciences 30(12): 891-894
Sarngadharan, M.G.; Popovic, M.; Bruch, L.; Schupbach, J.; Gallo, R.C. 1984: Antibodies reactive with human t lymphotropic retroviruses human t cell leukemia lymphoma virus iii in the serum of patients with acquired immuno deficiency syndrome Science 224(4648): 506-508
Verdier, M.; Denis, F.; Sangaré, A.; Barin, F.; Gershy-Damet, G.; Rey, J.L.; Soro, B.; Léonard, G.; Mounier, M.; Hugon, J. 1989: Prevalence of antibody to human T cell leukemia virus type 1 (HTLV-1) in populations of Ivory Coast, West Africa Journal of Infectious Diseases 160(3): 363-370
Wiktor, S.Z.; Pate, E.J.; Murphy, E.L.; Palker, T.J.; Champegnie, E.; Ramlal, A.; Cranston, B.; Hanchard, B.; Blattner, W.A. 1993: Mother-to-child transmission of human T-cell lymphotropic virus type I (HTLV-I) in Jamaica: association with antibodies to envelope glycoprotein (gp46) epitopes Journal of Acquired Immune Deficiency Syndromes 6(10): 1162-1167
Whang-Peng, J.; Bunn, P.A.; Knutsen, T.; Kao-Shan, C.S.; Broder, S.; Jaffe, E.S.; Gelmann, E.; Blattner, W.; Lofters, W.; Young, R.C. 1985: Cytogenetic studies in human T-cell lymphoma virus (HTLV)-positive leukemia-lymphoma in the United States Journal of the National Cancer Institute 74(2): 357-369
Seon, B.K. 1984: Specific killing of human T-leukemia cells by immunotoxins prepared with ricin a chain and monoclonal anti-human T-cell leukemia antibodies Cancer Research 44(1): 259-264
Ikeda, K.; Inaba, N.; Takamizawa, H. 1993: Vertical transmission human T-cell lymphotropic virus type-i (HTLV-I)--genetic diagnosis and assessment of the probable routes of HTLV-i infection Nihon Sanka Fujinka Gakkai Zasshi 45(11): 1283-1288
Aida, Y.; Amanuma, H.; Okada, K. 1994: Identification of tumor-associated antigen that is expressed on bovine leukemia virus-induced lymphosarcoma cells and expression of its human homologue in human T-cell lymphotrophic virus I-infected cell lines Leukemia 8(Suppl): S231-S234
Mori, N.; Prager, D. 1996: High levels of AP-2-binding activity in cell lines infected with human T-cell leukemia virus type I: possible enhancement of AP-2 binding by human T-cell leukemia virus type I tax Cancer Research 56(4): 779-782
Srivastava, B.I.; Wong-Staal, F.; Getchell, J.P. 1986: Human T-cell leukemia virus i provirus and antibodies in a captive gorilla with non-Hodgkin's lymphoma Cancer Research 46(9): 4756-4758
Arya, S.C.; Ashraf, S.J.; Pathak, V.P.; Parande, C.K. 1990: Antibodies to human T-cell leukemia virus type 1 in patients with malignancies in the Gizan area of Saudi Arabia Journal of Communicable Diseases 22(4): 281-282
Nicholson, J.K.; Cross, G.D.; Callaway, C.S.; McDougal, J.S. 1986: In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) Journal of Immunology 137(1): 323-329
Kawanishi, T.; Itamura, S.; Saida, T.; Kameyama, M.; Hatanaka, M. 1987: Prevalence and immunological properties of antibodies reactive with human T lymphotropic virus type i (HTLV-I) in sera from multiple sclerosis patients Rinsho Shinkeigaku 27(8): 963-968